THE country is seeking the transfer of mRNA technology to domestically manufacture Covid-19 vaccines, state media reported, as officials warned of supply issues until the end of the year.
MRNA vaccines, like that developed jointly by BionTech and Pfizer, prompt the human body to make a protein that is part of the virus, triggering an immune response.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
